LC determination of rosiglitazone in bulk and pharmaceutical formulation

Department of Physical Chemistry, School of Chemistry, Andhra University, 530 003, Visakhapatnam, India.
Journal of Pharmaceutical and Biomedical Analysis (Impact Factor: 2.98). 08/2002; 29(5):873-80. DOI: 10.1016/S0731-7085(02)00209-1
Source: PubMed


An isocratic reversed phase liquid chromatographic (RP-LC) method has been developed and subsequently validated for the determination of rosiglitazone and its related impurities. Separation was achieved with a Symmetry C18 column and sodium phosphate buffer (pH adjusted to 6.2):acetonitrile (50:50, v/v) as eluent, at a flow rate of 1.0 ml/min. UV detection was performed at 245 nm. The method is simple, rapid, selective and stability indicating. Indole was used as internal standard for the purpose of quantification of rosiglitazone. The described method is linear over a range of 0.45-10 microg/ml for related impurities and 180-910 microg/ml for assay of rosiglitazone. The method precision for the determination of assay and related compounds was below 1.0 and 3.6% RSD, respectively. The mean recoveries of impurities were found to be in the range of 95-102%. The percentage recoveries of Active Pharmaceutical Ingredient (API) from dosage forms ranged from 99.02 to 101.30. The method is useful in the quality control of bulk manufacturing and also in pharmaceutical formulations.

5 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The considerations behind the selection of reversed phase stationary phases in the pharmaceutical sciences and industry is reviewed throughout the various stages of drug development, from the lead discovery to the manufacturing stage. The selection of the appropriate stationary phase and column in every stage, according to the analytical needs, is described.
    Journal of Liquid Chromatography &amp Related Technologies 01/2004; 27(7-9-27):1-24. DOI:10.1081/JLC-120030606 · 0.61 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A simple, rapid, and precise reversed-phase liquid chromatographic method is developed for the simultaneous determination of metformin in combination with rosiglitazone. This method uses a Zorbax XDB C(18) 15-cm analytical column, a mobile phase of acetonitrile and buffer containing 10mM disodium hydrogen phsosphate, and 5mM sodium dodecyl sulphate in the ratio of 34:66 (v/v), and pH is adjusted to 7.1 with orthophosphoric acid. The instrumental settings are a flow rate of 1 mL/min, column temperature at 40 degrees C, and detector wavelength of 226 nm. The internal standard method is used for the quantitation of metformin and rosiglitazone. Methylparaben is used as an internal standard. The method is validated and shown to be linear. The correlation coefficients for metformin and rosiglitazone are 0.9996 and 0.9997, respectively. The relative standard deviation for six replicate measurements in two sets of each drug in the tablets is always less than 2%.
    Journal of chromatographic science 03/2004; 42(2):70-3. DOI:10.1093/chromsci/42.2.70 · 1.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Micellar electrokinetic chromatographic (MEKC) and high-performance liquid chromatographic (HPLC) methods were developed and subsequently validated for the determination of rosiglitazone (RSG) in coated tablet, a potent new oral antihyperglicemic agent. The electrophoretic separation was performed in a fused-silica capillary of total length 48.0 cm (effective length 39.5 cm, 75 microm i.d.) using 10 mM sodium tetraborate buffer (pH 9.0) containing 30 mM sodium dodecyl sulfate (SDS) as the background electrolyte (BGE). The separating voltage used was of 20 kV at 25 degrees C and the diode array detector was set at 247 nm. The MEKC method was compared with HPLC method using a RP-18 column (125 x 4.0mm i.d.) eluted with a mobile phase consisting of mixture of 25 mM potassium dihydrogen phosphate buffer and acetonitrile (55:45, v/v), adjusting the pH to 6.2 with dilute potassium hydroxide. Statistical analysis by Student's t-test showed no significant differences between the results obtained by two methods. The results indicated that MEKC can be used an alternative method to HPLC for the determination of rosiglitazone in pharmaceutical dosage form.
    Journal of Pharmaceutical and Biomedical Analysis 12/2004; 36(4):909-13. DOI:10.1016/j.jpba.2004.08.019 · 2.98 Impact Factor
Show more